These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7465407)

  • 1. [Hypocalcemia in cancer of the prostate: existence of an antivitamin D factor?].
    Arlet P; Blasco A; Duffaut M; Botreau Y; Le Tallec Y
    Nouv Presse Med; 1980 May; 9(24):1714-5. PubMed ID: 7465407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone metastasis with osteomalacia in cancer of the prostate. 2 cases].
    Delbarre F; Ghozlan R; Amor B
    Nouv Presse Med; 1975 Apr; 4(17):1277-8. PubMed ID: 168553
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency.
    Breen TL; Shane E
    J Clin Oncol; 2004 Apr; 22(8):1531-2. PubMed ID: 15084635
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer.
    Fokkema MI; de Heide LJ; van Schelven WD; Hamdy NA
    Neth J Med; 2005 Jan; 63(1):34-7. PubMed ID: 15719851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocalcemia associated with metastatic bone disease. A retrospective study.
    Raskin P; McClain CJ; Medsger TA
    Arch Intern Med; 1973 Oct; 132(4):539-43. PubMed ID: 4742409
    [No Abstract]   [Full Text] [Related]  

  • 6. A man with osteoblastic metastasis and hypocalcaemia.
    Lim SC; Tan CE; Aw TC; Khoo D; Eng P; Ho SC; Tai ES; Fok A
    Singapore Med J; 2000 Feb; 41(2):74-6. PubMed ID: 11063207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Major hypocalcemia in osteocondensing prostatic cancer].
    Wechsler B; Guillevin L; Ghozlan R; Crouzet J; Godeau P
    Sem Hop; 1977 Mar; 53(10):627-31. PubMed ID: 194316
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer.
    Szentirmai M; Constantinou C; Rainey JM; Loewenstein JE
    West J Med; 1995 Dec; 163(6):577-8. PubMed ID: 8553652
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin-sensitive osteomalacia in condensing bone metastases of prostatic origin. Apropos of 2 cases].
    Charhon S; Rouillat M; Bouvier M; Meunier PJ; Lejeune E
    Rev Rhum Mal Osteoartic; 1981 Jun; 48(6):469-76. PubMed ID: 7256162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic studies in a case of hypocalcemia and osteoblastic metastases.
    Tommaso CL; Tucci JR
    Arch Intern Med; 1979 Feb; 139(2):238-41. PubMed ID: 219791
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hypocalcaemia because of osteoblastic prostate carcinoma metastases.
    Yener S; Demir O; Ozdogan O; Akinci B; Yesil S
    Int J Clin Pract; 2008 Oct; 62(10):1630-1. PubMed ID: 18822033
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe hypocalcemia due to osteoblastic metastasis of prostate cancer.
    Diéguez Felechosa M; Noval Menéndez J; Manjón Miguelez L
    Med Clin (Barc); 2017 Mar; 148(6):287-288. PubMed ID: 28118964
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone metabolism and phosphorus metabolism in patients with prostate cancer: paracrine and endocrine effects produced by prostate neoplasm].
    Satani H; Yamakawa K; Kawamura J; Mori O; Saito K; Kato H; Tochigi H; Sakurai M; Kato T
    Hinyokika Kiyo; 1997 Dec; 43(12):849-54. PubMed ID: 9488931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
    Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A
    Prostate Cancer Prostatic Dis; 2009; 12(1):94-9. PubMed ID: 18332901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffuse disseminated osteosclerosis in metastatic cancer].
    Kameneva NA; Krylov AA
    Vrach Delo; 1972 Dec; 12():89-90. PubMed ID: 4659228
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of extremely advanced prostate cancer presenting hemolytic jaundice.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1994 Mar; 40(3):261-3. PubMed ID: 8178748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dense bone metastases and hypophosphatemic osteomalacia during the course of prostatic cancer (author's transl)].
    Quilichini R; Aubert L; Chauvin M; Chaffanjon P; Eisinger J
    Sem Hop; 1979 Dec 18-25; 55(43-44):2037-9. PubMed ID: 233449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hungry bone syndrome: persistent hypocalcemia related to osteoblastic bone metastases of prostate cancer.
    Riveros HA; Almodóvar LO; Danés CF; Domingo JP
    J Palliat Med; 2013 Dec; 16(12):1496-7. PubMed ID: 24160743
    [No Abstract]   [Full Text] [Related]  

  • 20. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
    Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
    Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.